Private limited company · Bærum
ABBOTT NORGE AS
ActiveWholesale of pharmaceutical and medical goods (46.460)
The life line 1997–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 604.0m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
ABBOTT NORGE AS is a private limited company in Bærum, founded in 1990, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Karl Andreas Almroth, and the chair of the board is Björn Fredrik Anders Björnulfson. In 2025 the company had NOK 604.0m in operating revenue and a net profit of NOK 29.5m.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 13 Nov 2026
- Number of employees 50 → 51
- Number of employees 51 → 50
- Annual accounts filed 2024 → 2025
- Godkjente årsregnskap
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
1 point
- OKEquity ratio 61.4%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 604.0m in 2025
Revenue
NOK 604.0m
+5.8% from 2024
20232025
Operating profit
NOK 31.3m
+42.5% from 2024
20232025
Net profit
NOK 29.5m
+40.6% from 2024
20232025
Equity
NOK 162.2m
+22.2% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 13%
- Depreciation 1%
- Other operating costs 8%
- Not specified in the source 73%
- Left as operating result 5%
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 61.4%
- ABBOTT NORGE AS, 2025
- Industry median, assumed: NOK 8.5m · 4.3% · 41.6% · +7.3%
Equity NOK 162.2m61% of the assets (NOK 264.0m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.
Finances
§ 06 Accounts
28 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 604,043 | 571,134 | 508,559 | |
| Operating profit | 31,320 | 21,977 | 30,609 | |
| Profit before tax | 38,051 | 27,209 | 33,377 | |
| Net profit | 29,451 | 20,943 | 25,778 | |
| Total assets | 263,990 | 284,073 | 210,169 | |
| Equity | 162,180 | 132,729 | 111,787 | |
| Liabilities | 101,811 | 151,344 | 98,382 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 28 years →
Management and ownership
§ 07 Officers
4 officers now
- ERNST & YOUNG ASAuditor since 2002
- Karl Andreas AlmrothChief executive since 2023
- Björn Fredrik Anders BjörnulfsonChair of the board since 2024
- Bradley Jay SlaterBoard member since 2023
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 4 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
May sign for the company:
Styrets leder og ett styremedlem i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Power of procuration:
Daglig leder alene.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 23 Aug 2026
Management and ownership
§ 09 Owners
None registered
No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.
Management and ownership
§ 10 Group
1 subsidiary
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
4 connections
- Person
- Company
3 people link ABBOTT NORGE AS to 2 other companies: Björn Fredrik Anders Björnulfson 2, Bradley Jay Slater 1 and Karl Andreas Almroth 1.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
19 since 2015
Events per year
20152026
Since 2015: 16 announcements, 7 register changes and 3 tenders won. Most happened in 2023 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 14 Nov 2026. Register changes are Intelligo's own observations. · All 19 events →
Events and registers
§ 14 Notices
16, latest 4 Aug 2026
- Godkjente årsregnskap
- Godkjente årsregnskap
- Signatur
Source: The Brønnøysund Register Centre's announcements ↗, read 14 Nov 2026 · All 16 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 12 Mar 1995
- VATRegistered
- The Register of Business EnterprisesRegistered 22 May 1990
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Å drive handel, produksjon, forskning, utvikling og markedsføring av produkter og produksjonsteknikker innen bioteknologi, deltakelse i andre selskaper, samt å yte administrative, operasjonelle, finansielle, forretningsmessige, forskningsmessige eller industrielle tjenester til enhver tredjepart, aksjeeier, datterselskap, tilknyttet selskap, herunder også lån, forskudd og garantier, samt annen virksomhet som hermed er forbundet.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
3 tenders
- 2023
- 2024
- 2025
- Won
- Lost
| Awarded | Contract | Buyer | Outcome |
|---|---|---|---|
| Feb 2025 | Intensjonkunngjøring Rammeavtale STI hepatitt St.Olav Hospital HF | SYKEHUSINNKJØP HF | Won |
| Dec 2024 | HPV-test og analyseplattform til helseforetak i Norge | SYKEHUSINNKJØP HF | Won |
| — | Intensjonskunngjøring: Pathfinder 350A til avd. for klinisk farmakologi- St. Olavs hospital HF | SYKEHUSINNKJØP HF | Won |
Source: Doffin and TED, read 4 Nov 2026. · All 3 tenders →
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 46.460
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of ABBOTT NORGE AS?
Karl Andreas Almroth, since 2023. § 07 - What was the revenue in 2025?
NOK 604.0m in the company. § 06 - Who can sign for ABBOTT NORGE AS?
Styrets leder og ett styremedlem i fellesskap. Daglig leder og ett styremedlem i fellesskap. § 08 - Who is the auditor?
ERNST & YOUNG AS, from 5 Jun 2002. § 07 - Where is ABBOTT NORGE AS based?
Rolfsbuktveien 4C, 1364 Fornebu. - When was ABBOTT NORGE AS founded?
12 Mar 1990, registered in the Register of Business Enterprises 22 May 1990. § 16
The answers come from the sections linked to, with their sources.